有应用华法林指征且植入冠状动脉支架患者抗栓策略的选择

[1] Anticoagulant and Antiplatelet Therapy Use in 426 Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention and Stent Implantation[J] . Juan M. Ruiz-Nodar,Francisco Marín,José Antonio Hurtado,José Valencia,Eduardo Pinar,Javier Pineda,Juan Ramón Gimeno,Francisco Sogorb,Mariano Valdés,Gregory Y.H. Lip.Journal of the American College of Cardiology . 2008 (8)

[2] Periprocedural and medium-term antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary angiography and intervention [J]. CORONARY ARTERY DISEASE, 2007, 18 (03) : 193 - 199

[3] Major Hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation [J]. CIRCULATION, 2007, 115 (21) : 2689 - 2696

[4] Anticoagulant and Antiplatelet Therapy Use in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention[J] . Gregory Y.H. Lip,Manas Karpha.Chest . 2006 (6)

[5] Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation[J] . James L Orford,Panayotis Fasseas,Steven Melby,Kelli Burger,Steven R Steinhubl,David R Holmes,Peter B Berger.American Heart Journal . 2004 (3)

[6] Safety of an Aspirin-Alone Regimen After Intracoronary Stenting With a Heparin-Coated Stent: Final Results of the HOPE （HEPACOAT and an Antithrombotic Regimen of Aspirin Alone） Study[J] . Roxana Mehran,Eve D. Aymong,Dale T. Ashby,Tim Fischell,Hall Whitworth,Robert Siegel,William Thomas,S. Chiu Wong,Raj Narasimaiah,Alexandra J. Lansky,Martin B. Leon.Circulation: Journal of the American Heart Association . 2003 (9)

[7] Aspirin alone antiplatelet regimen after intracoronary placement of the Carbostent?: The Antares study[J] . Antonio L.Bartorelli,DanielaTrabattoni,PieroMontorsi,FrancoFabbiocchi,StefanoGalli,PaoloRavagnani,LucaGrancini,SergioCozzi,AlessandroLoaldi.Cathet. Cardiovasc. Intervent. . 2002 (2)

[8] Randomized Multicenter Comparison of Conventional Anticoagulation Versus Antiplatelet Therapy in Unplanned and Elective Coronary Stenting: The Full Anticoagulation Versus Aspirin and Ticlopidine （FANTASTIC） Study[J] . Michel E. Bertrand,Victor Legrand,Jean Boland,Eckart Fleck,Johannes Bonnier,Hakan Emmanuelson,Matty Vrolix,Luc Missault,Sergio Chierchia,Michele Casaccia,Luigi Niccoli,Ali Oto,Christopher White,Michael Webb-Peploe,Eric Van Belle,Eugene P. McFadden.Circulation . 1998 (16)

[9] Aspirin,clopidogrel,and warfarin:Is the combination appropriate and effective or inappropriate and too dangerous. Hermosillo AJ,Spinler SA. Annals of Pharmacotherapy . 2008

[10] ACC/AHA/SCAI2005guideline update for percutaneous coronary intervention:a report of the American College of Cardiology/American Heart As-sociation Task Force on Practice Guidelines(ACC/AHA/SCAI writ-ing committee to update the2001guidelines for percutaneou. Smith Jr SC,Feldman TE,Hirshfeld Jr JW,et al. Circulation . 2006

[1] Anticoagulant and Antiplatelet Therapy Use in 426 Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention and Stent Implantation[J] . Juan M. Ruiz-Nodar,Francisco Marín,José Antonio Hurtado,José Valencia,Eduardo Pinar,Javier Pineda,Juan Ramón Gimeno,Francisco Sogorb,Mariano Valdés,Gregory Y.H. Lip.Journal of the American College of Cardiology . 2008 (8)

[2] Periprocedural and medium-term antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary angiography and intervention [J]. CORONARY ARTERY DISEASE, 2007, 18 (03) : 193 - 199

[3] Major Hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation [J]. CIRCULATION, 2007, 115 (21) : 2689 - 2696

[4] Anticoagulant and Antiplatelet Therapy Use in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention[J] . Gregory Y.H. Lip,Manas Karpha.Chest . 2006 (6)

[5] Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation[J] . James L Orford,Panayotis Fasseas,Steven Melby,Kelli Burger,Steven R Steinhubl,David R Holmes,Peter B Berger.American Heart Journal . 2004 (3)

[6] Safety of an Aspirin-Alone Regimen After Intracoronary Stenting With a Heparin-Coated Stent: Final Results of the HOPE （HEPACOAT and an Antithrombotic Regimen of Aspirin Alone） Study[J] . Roxana Mehran,Eve D. Aymong,Dale T. Ashby,Tim Fischell,Hall Whitworth,Robert Siegel,William Thomas,S. Chiu Wong,Raj Narasimaiah,Alexandra J. Lansky,Martin B. Leon.Circulation: Journal of the American Heart Association . 2003 (9)

[7] Aspirin alone antiplatelet regimen after intracoronary placement of the Carbostent?: The Antares study[J] . Antonio L.Bartorelli,DanielaTrabattoni,PieroMontorsi,FrancoFabbiocchi,StefanoGalli,PaoloRavagnani,LucaGrancini,SergioCozzi,AlessandroLoaldi.Cathet. Cardiovasc. Intervent. . 2002 (2)

[8] Randomized Multicenter Comparison of Conventional Anticoagulation Versus Antiplatelet Therapy in Unplanned and Elective Coronary Stenting: The Full Anticoagulation Versus Aspirin and Ticlopidine （FANTASTIC） Study[J] . Michel E. Bertrand,Victor Legrand,Jean Boland,Eckart Fleck,Johannes Bonnier,Hakan Emmanuelson,Matty Vrolix,Luc Missault,Sergio Chierchia,Michele Casaccia,Luigi Niccoli,Ali Oto,Christopher White,Michael Webb-Peploe,Eric Van Belle,Eugene P. McFadden.Circulation . 1998 (16)

[9] Aspirin,clopidogrel,and warfarin:Is the combination appropriate and effective or inappropriate and too dangerous. Hermosillo AJ,Spinler SA. Annals of Pharmacotherapy . 2008

[10] ACC/AHA/SCAI2005guideline update for percutaneous coronary intervention:a report of the American College of Cardiology/American Heart As-sociation Task Force on Practice Guidelines(ACC/AHA/SCAI writ-ing committee to update the2001guidelines for percutaneou. Smith Jr SC,Feldman TE,Hirshfeld Jr JW,et al. Circulation . 2006